These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 3543637

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K, Hamano T, Ichimaru N, Fujii N, Matsui I, Nonomura N, Tsubakihara Y, Rakugi H, Takahara S, Isaka Y.
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [Abstract] [Full Text] [Related]

  • 4. Absence of effect of 24,25-dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation.
    Friedlander MA, Horst RL, Hawker CD.
    Clin Nephrol; 1984 Oct; 22(4):206-10. PubMed ID: 6391769
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II.
    Rao DS, Parfitt AM, Kleerekoper M, Pumo BS, Frame B.
    J Clin Endocrinol Metab; 1985 Aug; 61(2):285-90. PubMed ID: 2989317
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis.
    Ambühl PM, Meier D, Wolf B, Dydak U, Boesiger P, Binswanger U.
    Am J Kidney Dis; 1999 Nov; 34(5):875-83. PubMed ID: 10561144
    [Abstract] [Full Text] [Related]

  • 11. Handling of phosphate by the transplanted kidney.
    Graf H, Kovarik J, Stummvoll HK, Wolf A, Pinggera WF.
    Proc Eur Dial Transplant Assoc; 1979 Nov; 16():624-9. PubMed ID: 398523
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D.
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [Abstract] [Full Text] [Related]

  • 14. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
    Wikström B, Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S, Wide L.
    Scand J Urol Nephrol Suppl; 1981 Apr; 61():II:1-26. PubMed ID: 6274002
    [Abstract] [Full Text] [Related]

  • 15. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia.
    Weiss M, Schechter P, Bab I, Mekhmandarov S, Bank H, Eisenstein Z.
    Isr J Med Sci; 1988 Jan; 24(1):46-50. PubMed ID: 3346150
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity.
    Yamashita H, Noguchi S, Moriyama T, Takamatsu Y, Sadanaga K, Uchino S, Watanabe S, Ogawa T.
    Surgery; 2005 Apr; 137(4):419-25. PubMed ID: 15800489
    [Abstract] [Full Text] [Related]

  • 18. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
    Salusky IB, Goodman WG.
    Adv Nephrol Necker Hosp; 1996 Apr; 25():289-302. PubMed ID: 8717632
    [Abstract] [Full Text] [Related]

  • 19. Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients.
    Dumoulin G, Hory B, Nguyen NU, Henriet MT, Bresson C, Regnard J, Saint-Hillier Y.
    Am J Nephrol; 1995 Apr; 15(3):238-44. PubMed ID: 7618649
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.